期刊文献+

溃疡性结肠炎患者血清低氧诱导因子-1α的检测及意义 被引量:6

Detection and significance of serum hypoxia inducible factor-1α in ulcerative colitis patients
原文传递
导出
摘要 [目的]检测溃疡性结肠炎患者血清低氧诱导因子-1α(HIF-1α)的含量,探讨其在溃疡性结肠炎发病机制中的调控作用及其与患者病情活动性和严重性的关系。[方法]采用酶联免疫吸附试验(ELISA)定量检测13例缓解期(缓解期组)、47例活动期(活动期组)UC患者及10例健康体检者(正常对照组)血清中HIF-1α含量,并对活动期组患者行肠镜检查,评价病情轻重程度。[结果]活动期组HIF-1α含量[(73.21±28.65)ng/L]显著高于缓解期组[(44.54±14.75)ng/L]与正常对照组[(42.83±15.49)ng/L],P<0.05;缓解期组与正常对照组比较差异无统计学意义(P>0.05)。HIF-1α与病情活动性、病情分型及内镜表现分级呈正相关。[结论]HIF-1α作为一种转录因子可能在UC发病机制中充当重要角色,并可能作为评价UC患者病情活动性及严重程度的良好指标。 [Objective]To detect the serum hypoxia inducible factor-1 alpha(HIF-1α)in ulcerative colitis (UC)patients,explore its role in the pathogenesis of UC and its relationship with disease activity and se- verity. [Methods]Enzyme-linked immunosorbent assay(ELISA)was performed to detect the expression of HIF-1α in serum in 10 healthy controls,13 cases of remission UC and 47 cases of active UC ,the active UC patients underwent the colonoseopy to evaluate disease severity. [Results]The expression of HIF-1α in serum was significantly higher in active UC patients UC patients([73.21 ± 28. 65]ng/L)than those in re- mission UC patients ([44. 54 ± 14. 75] ng/L) and control group ([42. 83 ± 15.49] ng/L), P〈0.05 ; and no sig- nificant difference between remission UC patients and control group(P〉0. 05). The level of HIF-la in serum was positively correlated with disease activity, disease severity and endoscopic grading. [Conclusion] HIF-1α, as a transcription factor, may play an important role in the pathogenesis of ulcerative colitis,and may serve as a good index to evaluate disease activity and severity in patients with UC.
出处 《临床消化病杂志》 2014年第2期93-95,共3页 Chinese Journal of Clinical Gastroenterology
关键词 结肠炎 溃疡性 低氧诱导因子-1Α 酶联免疫吸附测定 ulcerative colitis hypoxia inducible factor-1α enzyme-linked immunosorbent assay
  • 相关文献

参考文献5

二级参考文献98

  • 1肖颖丽,梁志清,邱敏.卵巢上皮性肿瘤中缺氧诱导因子-1α的表达及意义[J].中国现代医学杂志,2005,15(21):3251-3254. 被引量:2
  • 2潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 3潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 4樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 5欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 6Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 7Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 8Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 9Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 10Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.

共引文献1047

同被引文献46

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部